ABATA Trademark

Trademark Overview


On Friday, January 22, 2021, a trademark application was filed for ABATA with the United States Patent and Trademark Office. The USPTO has given the ABATA trademark a serial number of 90481704. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, July 5, 2024. This trademark is owned by Velox Therapeutics, Inc.. The ABATA trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies

Pharmaceutical preparations for T Cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders; biochemical, namely, monoclonal antibodies for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders

Providing information regarding the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders by means of a website

General Information


Serial Number90481704
Word MarkABATA
Filing DateFriday, January 22, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements


Goods and ServicesCustom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies
Goods and ServicesPharmaceutical preparations for T Cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders; biochemical, namely, monoclonal antibodies for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders
Translation of Words in MarkThe wording Abata has no meaning in a foreign language.
Goods and ServicesProviding information regarding the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders by means of a website

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABATA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameABATA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02116

Party NameVelox Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Thursday, May 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 26, 2021NEW APPLICATION ENTERED
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 9, 2021ASSIGNED TO EXAMINER
Thursday, August 12, 2021NON-FINAL ACTION WRITTEN
Thursday, August 12, 2021NON-FINAL ACTION E-MAILED
Thursday, August 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 29, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022SOU EXTENSION 1 FILED
Thursday, July 7, 2022SOU EXTENSION 1 GRANTED
Tuesday, January 3, 2023SOU EXTENSION 2 FILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 3, 2023SOU EXTENSION 2 GRANTED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 3 FILED
Wednesday, June 28, 2023SOU EXTENSION 3 GRANTED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU EXTENSION 4 GRANTED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 4 FILED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 5, 2024SOU EXTENSION 5 GRANTED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2024SOU EXTENSION 5 FILED
Monday, October 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 18, 2024TEAS STATEMENT OF USE RECEIVED